Quarterly Results • Search Archive

Mankind Pharma Limited
Results, Financials & Updates

Follow Mankind Pharma Limited results and financial updates in one company page: latest revenue or income, profit, margins, quarter comparisons, what changed and detailed Nivata Results deep dives.

2 published deep dives 2 quarters 1 sector

Company Overview

Mankind Pharma Limited: latest results and financials

Latest covered quarterQ2 FY27NSE: MANKIND
Revenue from operations₹4,338.00 CrReported in the latest covered quarter
Profit after tax₹716.00 CrReported in the latest covered quarter
EBITDA margin27.10%Latest available reported margin
About the business in Nivata's latest coverage

Mankind Pharma Limited operates as a prominent Indian pharmaceutical and healthcare company, engaged in developing, manufacturing, and marketing a diverse range of formulation products, acute and chronic medications, consumer healthcare brands, and active pharmaceutical ingredients (APIs). The company commercialises its extensive portfolio across domestic and international markets, supported by an extensive domestic field force exceeding 16,800 representatives and a widespread distribution network reaching medical practitioners across general practice, specialty, and super-specialty segments.

Quarter History

Mankind Pharma reported trend

Each row comes from the corresponding Nivata Results brief. Reporting scope can differ between quarters; open the quarter for full context.

QuarterRevenue / incomePATMargin
Q2 FY27Consolidated₹4,338.00 Cr₹716.00 Cr27.10%Open ↗
Q1 FY27Consolidated₹4,030.59 Cr₹574.09 Cr—Open ↗
← All quarterly results

Quarter history

Mankind Pharma Limited Results & Financials

Latest Nivata coverage: Q2 FY27 · revenue ₹4,338.00 Cr · PAT ₹716.00 Cr.